Table 2.
GvHD at ruxolitinib initiation, indication for ruxolitinib, diarrhea, and outcome of GvHD. CNI: calcineurin-inhibitor.
| Patient | GvHD-control at initiation of ruxolitinib |
Indication for ruxolitinib |
Diarrhea at ruxolitinib initiation |
Response of GvHD to ruxolitinib |
|---|---|---|---|---|
| #1 | Controlled | (i) CNI-replacement (ii) Steroid sparing |
None | Yes |
| #2 | Uncontrolled | (i) Uncontrolled GvHD | Severe | No |
| #3 | Partially controlled | (i) CNI-replacement (ii) Steroid-sparing |
None | Yes |
| #4 | Uncontrolled | (i) Uncontrolled GvHD | Severe | No |
| #5 | Uncontrolled | (i) Uncontrolled GvHD | Severe | No |
| #6 | Partially controlled | (i) Steroid sparing | None | Yes |
| #7 | Partially controlled | (i) Steroid sparing | None | Yes |
| #8 | Uncontrolled | (i) Uncontrolled GvHD | Severe | No |